Neurotoxicity of dextrorphan

Archives of Medical Research

Volumn 30, Issue 2, 1999, Pages 125-127

  Ortiz, Genaro G ^a,b   Guerrero, Juan M ^a   Reiter, Russel J ^a   Poeggeler, Burkhard H ^a   Bitzer Quintero, Oscar K ^a,b   Feria Velasco, Alfredo ^a,b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b Instituto de Neurociencias   (Mexico)

^c CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

Author keywords

Dextrorphan; Neurotoxicity; NMDA antagonists; Posterior cingulate cortex

Indexed keywords

DEXTRORPHAN; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL TISSUE; ARTICLE; CELL GRANULE; CELL STRUCTURE; CELL VACUOLE; CHROMATIN; CHROMATIN CONDENSATION; CINGULATE GYRUS; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; BRAIN; DEXTRORPHAN; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032985120     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-0128(98)00020-7     Document Type: Article

References (16)

1. Price M.T., Sesma M.A. NMDA Antagonist neurotoxicity. mechanism and prevention Science. 254:1991;1515.
2. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists. channel blockers and 2,3-benzodiazepines Trends Pharmacol. 14:1993;325.
3. Muir K.W., Lees K.R. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 25:1995;503.
4. Collingridge G.L., Singer W. Excitatory amino acids receptors and synaptic plasticity. TIPS. 11:1990;290.
5. Cooper J.R., Bloom F.E., Roth R.H. Cellular mechanisms in learning and memory. In. The biochemical basis of neuropharmacology 6th ed:1991;Oxford University Press, New York. 32.p.
6. Albers G.W., Goldberg M.P., Choi D.W. Do NMDA antagonists prevent neuronal injury? Yes. Arch Neurol. 49:1992;418.
7. Fix A.S., Horn J.W., Johnson C.A., Truex L., Smith R., Gomez E. Onset of neuronal vacuolization induced by the NMDA antagonist MK (+)801 in the rat retrosplenial cortex. Vet Pathol. 30:1993;464.
8. Olney J.W. Neurotoxicity of NMDA receptors antagonists. an overview Psychopharmacology. 30:1994;533.
9. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev. 20:1995;250.
10. Wendling W.W., Chen D., Daniels F.B., Monteforte M.R., Fisher M.B., Harakal C., Carlson C. The effects of N-methyl-D-aspartate agonists and antagonists on isolated bovine cerebral arteries. Anesth Analg. 82:1996;264.
11. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360.
12. Trube G., Netzer R. Dextromethorphan. cellular effects reducing neuronal hyperactivity Epilepsia. 35:1994;562.
13. Dematteis M., Mallaret M., Baubichon D., Pernot-Marino I., Lallament G. Evaluation of dextromethorphan and dextrorphan as a preventive treatment of soman toxicity in mice. Neurosci Lett. 234:1997;91.
14. Fix A.S., Wightman K.A., Johnson C.A., Truex L., Smith R., Gomez E., Long G.G., Storts R.W. Dose-dependent neuronal degeneration induced by the NMDA antagonist MK(+)801 in the rat cerebral cortex. Vet Pathol. 29:1992;447.
15. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.G., Storts R.W., Farber N.B., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate). a light and electron microscopic evaluation of the rat retrosplenial cortex Exp Neurol. 123:1993;204.
16. Fix A.S., Long G.G., Wosniak D.F., Olney J.W. Pathomorphologic effects of N-methyl-D- aspartate (NMDA) antagonists in the rat posterior cingulate/retrosplenial cerebral cortex. a review Drug Dev Res. 32:1994;147.